Insiders · INFI

Lawrence E Bloch

Officer at Infinity Pharmaceuticals, Inc. (INFI)

Lawrence E Bloch has filed 1 insider report with the SEC since January 2022, as officer at Infinity Pharmaceuticals, Inc. (INFI). The latest filing, on January 12, 2022, reports grant or award at Infinity Pharmaceuticals, Inc. (INFI).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Lawrence E Bloch is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Infinity Pharmaceuticals, Inc. logo
INFI
Infinity Pharmaceuticals, Inc.
OfficerJan 12, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Questions about Lawrence E Bloch

What is Lawrence E Bloch's role at Infinity Pharmaceuticals, Inc.?
Lawrence E Bloch reports to the SEC as officer at Infinity Pharmaceuticals, Inc. (INFI), according to the latest filing on January 12, 2022.
Has Lawrence E Bloch bought or sold stock recently?
No open-market purchases or sales by Lawrence E Bloch are on file. The filings report grant or award.
How do I get alerts when Lawrence E Bloch files?
Follow Lawrence E Bloch on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Lawrence E Bloch (SEC CIK 0001244822). Totals count each trade once, skipping amendments whose original is on file, from Jan 12, 2022 on. View on SEC EDGAR